170 related articles for article (PubMed ID: 31573846)
21. Tumor Necrosis Factor, but Not Neutrophils, Alters the Metabolic Profile in Acute Experimental Arthritis.
Oliveira MC; Tavares LP; Vago JP; Batista NV; Queiroz-Junior CM; Vieira AT; Menezes GB; Sousa LP; van de Loo FA; Teixeira MM; Amaral FA; Ferreira AV
PLoS One; 2016; 11(1):e0146403. PubMed ID: 26742100
[TBL] [Abstract][Full Text] [Related]
22. The IL-8-CXCR1/2 axis contributes to diabetic kidney disease.
Loretelli C; Rocchio F; D'Addio F; Ben Nasr M; Castillo-Leon E; Dellepiane S; Vergani A; Abdelsalam A; Assi E; Maestroni A; Usuelli V; Bassi R; Pastore I; Yang J; El Essawy B; Elased KM; Fadini GP; Ippolito E; Seelam AJ; Pezzolesi M; Corradi D; Zuccotti GV; Gallieni M; Allegretti M; Niewczas MA; Fiorina P
Metabolism; 2021 Aug; 121():154804. PubMed ID: 34097917
[TBL] [Abstract][Full Text] [Related]
23. Differential activation and regulation of CXCR1 and CXCR2 by CXCL8 monomer and dimer.
Nasser MW; Raghuwanshi SK; Grant DJ; Jala VR; Rajarathnam K; Richardson RM
J Immunol; 2009 Sep; 183(5):3425-32. PubMed ID: 19667085
[TBL] [Abstract][Full Text] [Related]
24. Probing the role of CXC motif in chemokine CXCL8 for high affinity binding and activation of CXCR1 and CXCR2 receptors.
Joseph PR; Sarmiento JM; Mishra AK; Das ST; Garofalo RP; Navarro J; Rajarathnam K
J Biol Chem; 2010 Sep; 285(38):29262-9. PubMed ID: 20630874
[TBL] [Abstract][Full Text] [Related]
25. G31P, CXCR1/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates high‑dose cisplatin-induced nephrotoxicity.
Li L; Khan MN; Li Q; Chen X; Wei J; Wang B; Cheng JW; Gordon JR; Li F
Oncol Rep; 2015 Feb; 33(2):751-7. PubMed ID: 25504010
[TBL] [Abstract][Full Text] [Related]
26. Oleanolic acid improves hepatic insulin resistance via antioxidant, hypolipidemic and anti-inflammatory effects.
Wang X; Liu R; Zhang W; Zhang X; Liao N; Wang Z; Li W; Qin X; Hai C
Mol Cell Endocrinol; 2013 Aug; 376(1-2):70-80. PubMed ID: 23791844
[TBL] [Abstract][Full Text] [Related]
27. Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2.
Moriconi A; Cesta MC; Cervellera MN; Aramini A; Coniglio S; Colagioia S; Beccari AR; Bizzarri C; Cavicchia MR; Locati M; Galliera E; Di Benedetto P; Vigilante P; Bertini R; Allegretti M
J Med Chem; 2007 Aug; 50(17):3984-4002. PubMed ID: 17665889
[TBL] [Abstract][Full Text] [Related]
28. Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2.
Kaur M; Singh D
J Pharmacol Exp Ther; 2013 Oct; 347(1):173-80. PubMed ID: 23912333
[TBL] [Abstract][Full Text] [Related]
29. GDC-0941 and CXCL8 (3-72) K11R/G31P combination therapy confers enhanced efficacy against breast cancer.
Li X; Zhang Y; Walana W; Zhao F; Li F; Luo F
Future Oncol; 2020 May; 16(14):911-921. PubMed ID: 32285685
[No Abstract] [Full Text] [Related]
30. Behavioral alterations in rat offspring following maternal immune activation and ELR-CXC chemokine receptor antagonism during pregnancy: implications for neurodevelopmental psychiatric disorders.
Ballendine SA; Greba Q; Dawicki W; Zhang X; Gordon JR; Howland JG
Prog Neuropsychopharmacol Biol Psychiatry; 2015 Mar; 57():155-65. PubMed ID: 25445065
[TBL] [Abstract][Full Text] [Related]
31. Expression of CXCL8, CXCR1, and CXCR2 in neurons and glial cells of the human and rabbit retina.
Goczalik I; Ulbricht E; Hollborn M; Raap M; Uhlmann S; Weick M; Pannicke T; Wiedemann P; Bringmann A; Reichenbach A; Francke M
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4578-89. PubMed ID: 18552386
[TBL] [Abstract][Full Text] [Related]
32. A novel, orally active CXCR1/2 receptor antagonist, Sch527123, inhibits neutrophil recruitment, mucus production, and goblet cell hyperplasia in animal models of pulmonary inflammation.
Chapman RW; Minnicozzi M; Celly CS; Phillips JE; Kung TT; Hipkin RW; Fan X; Rindgen D; Deno G; Bond R; Gonsiorek W; Billah MM; Fine JS; Hey JA
J Pharmacol Exp Ther; 2007 Aug; 322(2):486-93. PubMed ID: 17496165
[TBL] [Abstract][Full Text] [Related]
33. CXCL8((3-73))K11R/G31P antagonizes the neutrophil chemoattractants present in pasteurellosis and mastitis lesions and abrogates neutrophil influx into intradermal endotoxin challenge sites in vivo.
Li F; Zhang X; Mizzi C; Gordon JR
Vet Immunol Immunopathol; 2002 Nov; 90(1-2):65-77. PubMed ID: 12406656
[TBL] [Abstract][Full Text] [Related]
34. Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2.
Maeda DY; Peck AM; Schuler AD; Quinn MT; Kirpotina LN; Wicomb WN; Fan GH; Zebala JA
J Med Chem; 2014 Oct; 57(20):8378-97. PubMed ID: 25254640
[TBL] [Abstract][Full Text] [Related]
35. CXCR1/2 Inhibitor Ladarixin Ameliorates the Insulin Resistance of 3T3-L1 Adipocytes by Inhibiting Inflammation and Improving Insulin Signaling.
Castelli V; Brandolini L; d'Angelo M; Giorgio C; Alfonsetti M; Cocchiaro P; Lombardi F; Cimini A; Allegretti M
Cells; 2021 Sep; 10(9):. PubMed ID: 34571976
[TBL] [Abstract][Full Text] [Related]
36. Treatment with DF 2162, a non-competitive allosteric inhibitor of CXCR1/2, diminishes neutrophil influx and inflammatory hypernociception in mice.
Cunha TM; Barsante MM; Guerrero AT; Verri WA; Ferreira SH; Coelho FM; Bertini R; Di Giacinto C; Allegretti M; Cunha FQ; Teixeira MM
Br J Pharmacol; 2008 May; 154(2):460-70. PubMed ID: 18362895
[TBL] [Abstract][Full Text] [Related]
37. Tangshen formula attenuates hepatic steatosis by inhibiting hepatic lipogenesis and augmenting fatty acid oxidation in db/db mice.
Kong Q; Zhang H; Zhao T; Zhang W; Yan M; Dong X; Li P
Int J Mol Med; 2016 Dec; 38(6):1715-1726. PubMed ID: 27840945
[TBL] [Abstract][Full Text] [Related]
38. Probiotics improve re-epithelialization of scratches infected by Porphyromonas gingivalis through up-regulating CXCL8-CXCR1/CXCR2 axis.
Albuquerque-Souza E; Ishikawa KH; Amado PP; Nicoli JR; Holzhausen M; Mayer MPA
Anaerobe; 2021 Dec; 72():102458. PubMed ID: 34547426
[TBL] [Abstract][Full Text] [Related]
39. The collagen-breakdown product N-acetyl-Proline-Glycine-Proline (N-alpha-PGP) does not interact directly with human CXCR1 and CXCR2.
de Kruijf P; Lim HD; Overbeek SA; Zaman GJ; Kraneveld AD; Folkerts G; Leurs R; Smit MJ
Eur J Pharmacol; 2010 Sep; 643(1):29-33. PubMed ID: 20599927
[TBL] [Abstract][Full Text] [Related]
40. Intracellular cross-talk between the GPCR CXCR1 and CXCR2: role of carboxyl terminus phosphorylation sites.
Attal H; Cohen-Hillel E; Meshel T; Wang JM; Gong W; Ben-Baruch A
Exp Cell Res; 2008 Jan; 314(2):352-65. PubMed ID: 17996233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]